Avoro Capital Advisors LLC Q3 2022 Filing
Filed November 14, 2022
Portfolio Value
$5.4T
Holdings
39
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (39 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | APLSAPELLIS PHARMACEUTICALS INC | 10,125,000 | $691.5B | 12.78% | |
| 2 | UTHUNITED THERAPEUTICS CORP | 2,926,500 | $612.8B | 11.32% | |
| 3 | ARGXARGENX SE | 1,265,555 | $446.8B | 8.25% | |
| 4 | MRTXEURMIRATI THERAPEUTICS INC | 5,550,555 | $387.7B | 7.16% | |
| 5 | SRPTSAREPTA THERAPEUTICS INC | 3,175,000 | $351.0B | 6.48% | |
| 6 | HZNPHORIZON THERAPEUTICS PLC | 5,125,000 | $317.2B | 5.86% | |
| 7 | BMRNBIOMARIN PHARMACEUTICAL INC | 3,555,555 | $301.4B | 5.57% | |
| 8 | ASNDASCENDIS PHARMA | 2,850,000 | $294.3B | 5.44% | |
| 9 | AM6AMICUS THERAPEUTICS INC | 26,800,000 | $279.8B | 5.17% | |
| 10 | SGENUSDSEAGEN INC | 1,865,000 | $255.2B | 4.71% | |
| 11 | ALNYALNYLAM PHARMACEUTICALS INC | 1,105,000 | $221.2B | 4.09% | |
| 12 | XENEXENON PHARMACEUTICALS INC | 4,900,000 | $176.9B | 3.27% | |
| 13 | BCRXBIOCRYST PHARMACEUTICALS INC | 9,050,000 | $114.0B | 2.11% | |
| 14 | OPHTEURIVERIC BIO INC | 5,900,000 | $105.8B | 1.96% | |
| 15 | MDGLMADRIGAL PHARMACEUTICALS INC | 1,535,000 | $99.8B | 1.84% | |
| 16 | KRYSKRYSTAL BIOTECH INC | 1,275,000 | $88.9B | 1.64% | |
| 17 | IOVAIOVANCE BIOTHERAPEUTICS INC | 9,020,000 | $86.4B | 1.60% | |
| 18 | SNDXSYNDAX PHARMACEUTICALS INC | 2,222,222 | $53.4B | 0.99% | |
| 19 | —MERSANA THERAPEUTICS INC | 7,550,000 | $51.0B | 0.94% | |
| 20 | KURAKURA ONCOLOGY INC | 3,525,000 | $48.2B | 0.89% | |
| 21 | KYMRKYMERA THERAPEUTICS INC | 2,169,230 | $47.2B | 0.87% | |
| 22 | WHWKAADI BIOSCIENCES INC | 2,849,402 | $40.3B | 0.74% | |
| 23 | DSGNDESIGN THERAPEUTICS INC | 2,222,222 | $37.2B | 0.69% | |
| 24 | PMVPPMV PHARMACEUTICALS INC | 3,060,000 | $36.4B | 0.67% | |
| 25 | CBAYUSDCYMABAY THERAPEUTICS INC | 10,300,000 | $36.0B | 0.67% | |
| 26 | RAREULTRAGENYX PHARMACEUTICAL INC | 750,000 | $31.1B | 0.57% | |
| 27 | MNKDMANNKIND CORP | 9,100,000 | $28.1B | 0.52% | |
| 28 | GLUEMONTE ROSA THERAPEUTICS INC | 3,363,333 | $27.5B | 0.51% | |
| 29 | RNAAVIDITY BIOSCIENCES INC | 1,450,000 | $23.7B | 0.44% | |
| 30 | —DICE THERAPEUTICS INC | 1,075,000 | $21.8B | 0.40% | |
| 31 | MRNS*MARINUS PHARMACEUTICALS INC | 3,150,000 | $20.9B | 0.39% | |
| 32 | NUVLNUVALENT INC | 1,049,471 | $20.4B | 0.38% | |
| 33 | AMLXAMYLYX PHARMACEUTICALS INC | 650,000 | $18.3B | 0.34% | |
| 34 | FRXFENNEC PHARMACEUTICALS INC | 1,200,000 | $9.7B | 0.18% | |
| 35 | RLAYRELAY THERAPEUTICS INC | 400,000 | $8.9B | 0.17% | |
| 36 | AMRNAMARIN CORP PLC | 6,000,000 | $6.5B | 0.12% | |
| 37 | TNGXTANGO THERAPEUTICS INC | 1,550,000 | $5.6B | 0.10% | |
| 38 | IOBTIO BIOTECH INC | 2,055,883 | $5.6B | 0.10% | |
| 39 | BCABBIOATLA INC | 575,000 | $4.4B | 0.08% |